Pharmos patents expiration
1. Lotemax patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5540930 | PHARMOS | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct, 2013
(10 years ago) | |
Drugs and Companies using LOTEPREDNOL ETABONATE ingredient
Market Authorisation Date: 09 March, 1998
Treatment: NA
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
LOTEMAX family patents
